Adicet Bio, Inc. (ACET)
NASDAQ: ACET · Real-Time Price · USD
0.6936
-0.0251 (-3.49%)
At close: May 23, 2025, 4:00 PM
0.7282
+0.0346 (4.99%)
After-hours: May 23, 2025, 7:33 PM EDT
Adicet Bio Market Cap
Adicet Bio has a market cap or net worth of $57.37 million as of May 23, 2025. Its market cap has decreased by -57.69% in one year.
Market Cap
57.37M
Enterprise Value
-76.83M
1-Year Change
-57.69%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since September 16, 2020, Adicet Bio's market cap has decreased from $301.68M to $57.37M, a decrease of -80.98%. That is a compound annual growth rate of -29.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 57.37M | -27.63% |
| Dec 31, 2024 | 79.27M | -2.83% |
| Dec 29, 2023 | 81.58M | -78.70% |
| Dec 30, 2022 | 383.09M | -44.04% |
| Dec 31, 2021 | 684.61M | 148.60% |
| Dec 31, 2020 | 275.39M | -8.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |